Gausi, K., Wiesner, L., Norman, J., Wallis, C. L., Onyango‐Makumbi, C., Chipato, T., Haas, D. W., Browning, R., Chakhtoura, N., Montepiedra, G., Aaron, L., McCarthy, K., Bradford, S., Vhembo, T., Stranix‐Chibanda, L., Masheto, G. R., Violari, A., Mmbaga, B. T., Aurpibul, L., Bhosale, R., Nevrekhar, N., Rouzier, V., Kabugho, E., Mutambanengwe, M., Chanaiwa, V., Nyati, M., Mhembere, T., Tongprasert, F., Hesseling, A., Shin, K., Zimmer, B., Costello, D., Jean‐Philippe, P., Sterling, T. R., Theron, G., Weinberg, A., Gupta, A., Denti, P., & , (2021). pharmacokinetics and Drug‐Drug Interactions of Isoniazid and Efavirenz in Pregnant Women Living With HIV in High TB Incidence Settings: Importance of Genotyping. Clinical pharmacology & therapeutics, 109(4), 1034–1044. http://access.bl.uk/ark:/81055/vdc_100124349327.0x000063